https://www.business-standard.com/companies/news/dr-reddys-zytorvi-dcgi-approval-oesophageal-cancer-toripalimab-126102100639_1.html
Dr Reddy's receives DCGI approval for toripalimab in ESCC treatment. The drug is used with cisplatin and paclitaxel for advanced cancer. Approval covers first-line therapy for unresectable cases.
Image:
#cancer #drug #india #treatment
Dr Reddy's receives DCGI approval for toripalimab in ESCC treatment. The drug is used with cisplatin and paclitaxel for advanced cancer. Approval covers first-line therapy for unresectable cases.
Image:
#cancer #drug #india #treatment
Views: 3
Categories: Projects & Resources [c5]